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Introduction. In recent years new adjuvant radiation schedules in breast cancer have been incorporated to our daily practice
with a tendency to hypofractionation or simultaneous integrated boost (SIB). Toxicity is frequently a concern when using these
schemes.
Purpose. To compare dosimetry parameters of sequential versus SIB in breast adjuvant radiotherapy with 3D conventional
radiotherapy. To identify factors related to toxicity.
Material and methods. In 2011, 213 patients were treated with different schemes of adjuvant radiotherapy in breast cancer. We
retrospectively analyse the relationship of acute toxicity with different variables: PTVvolume, PTVboost-volumen, Radiation
scheme, Total Dose, age, breast right/left, quadrant, grade, time of year, previous chemotherapy and hormone-therapy. ANOVA
analysis for quantitative variables and Kruskal–Wallis for qualitative variables. Retrospective dosimetry comparison of 63 cases of
sequential boost (25–35 fractions, 2Gy/fraction) versus 57 cases of SIB (2.30, 2.47 or 2.58Gy/fraction) Dose equivalence calculated
according to the Linear Quadratic Model considering an alpha/beta of 4.6Gy.
Results. Skin acute toxicity G0 23.9%, G1 46.9%, G2 24.4%, G3 4.7%. No cardiac acute toxicity was reported and only 3 patients
presented G1 pulmonary acute toxicity (not included in the statistical analysis). We found statistical differences with PTV volume
(p=0.000) and sequential boost scheme (p=0.005) related to acute skin toxicity. Dosimetry comparison with T-student analysis
did not ﬁnd statistical signiﬁcance between the mean differences.
Conclusions. The mean differences of the dosimetry parameters analyzed were not signiﬁcant with a conﬁdence interval of 95%.
We found statistically signiﬁcant differences of acute skin toxicity in relation to PTV volume and sequential boost.
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Purpose. The aim of this study was to demonstrate feasibility and analyse dosimetric differences in prone and supine position
breast cancer radiotherapy in women with large or pendulous breast.
Methods. Ten post-lumpectomy breast cancer patients underwent supine and prone CT-based treatment plan. On each data-set,
the whole breast, the ipsilateral lung and the heart were outlined. Multisegment tangential-ﬁelds plans were generated for each
position. Target coverage, homogeneity, overdosage outside breast and organ at risk sparing were analyzed and compared for
supine and prone position.
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